Implantation Success and Infection in Cardiovascular Implantable Electronic Device Procedures Utilizing an Antibacterial Envelope

Implantation Success and Infection in Cardiovascular Implantable Electronic Device Procedures Utilizing an Antibacterial Envelope
复制标题

DOI:
10.1111/j.1540-8159.2010.02931.x
复制
发表时间:
2011-02-01
影响因子:
1.8
通讯作者:
Sohail, Muhammad R.
Sohail, Muhammad R.
中科院分区:
工程技术4区
文献类型:
--
作者:
Bloom, Heather L.;Constantin, Luis;Sohail, Muhammad R.

文献摘要

被引文献

相似文献

研究方法:本研究在10个美国学术、社区和退伍军人事务部医疗中心招募了使用抗菌信封的连续CIED手术。排除了先前CIED感染或抗菌信封标签外使用的预防后的程序。624个合格程序(年龄70 ± 13岁,68.1%男性,27.2%肾功能不全,35.4%口服抗凝剂使用,67.8%置换/翻修手术)使用起搏器(35%),植入式心律转复除颤器(ICD)(29%),心脏除颤器(CRT-D)治疗(36%)。近一半的患者(49%)至少有三个预先确定的CIED感染风险因素。CIED植入在621例手术中获得成功(99.5% [95%置信区间(CI)98.8-99.9])。在1.9 +/- 2.4个月随访后,有3例严重感染(0.48% [95%CI 0.17-1.40])。感染发生在1例ICD翻修和2例CRT-D置换后。有7人死亡;结论:使用抗菌包膜的CIED手术具有较高的CIED植入成功率(> 99%)。虽然随访时间较短,但在CIED感染高危人群中,感染率也较低(< 0.50%)。(PACE 2011; 34:133-142)。
Methods: This study enrolled consecutive CIED procedures utilizing the antibacterial envelope at 10 US academic, community, and Veterans Affairs medical centers. Procedures following an explantation for a prior CIED infection or off-label use of the antibacterial envelope were excluded.Results: The 624 eligible procedures (age 70 +/- 13 years, 68.1% men, 27.2% renal insufficiency, 35.4% oral anticoagulant use, 67.8% replacement/revision procedures) utilized pacemakers (35%), implantable cardioverter-defibrillators (ICD)(29%), and cardiac resynchronization therapy with defibrillator devices (CRT-D)(36%). Nearly half of the patients (49%) had at least three predefined risk factors for CIED infection. CIED implantation was successful in 621 procedures (99.5% [95% confidence interval (CI) 98.8-99.9]). There were three major infections (0.48% [95%CI 0.17-1.40]) after 1.9 +/- 2.4 months follow-up. The infections followed one ICD revision and two CRT-D replacements. There were seven deaths; none was a result of the antibacterial envelope or the CIED procedure.Conclusions: CIED procedures that utilized an antibacterial envelope had a high rate of CIED implantation success (> 99%). Although the follow-up to date is short, there was also a low rate of infection (< 0.50%) in this population at high risk for CIED infection. (PACE 2011; 34:133-142).